SCHEMBL4907293

SCHEMBL4907293

CCN(Sc1ncccc1C(F)(F)F)S(=O)(=O)c1ccc(C)c(C(=O)O)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.39
ALDH1A1 P00352 7/20 0.38
KDM4E B2RXH2 3/20 0.38
HTT P42858 2/20 0.38
SMN1; SMN2 Q16637 4/20 0.38
RAB9A P51151 1/20 0.38
DHODH Q02127 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
HPGD P15428 1/20 0.36
ALOX15 P16050 1/20 0.36
HSD17B10 Q99714 1/20 0.36
PTGDR2 Q9Y5Y4 2/20 0.36
TRPM8 Q7Z2W7 1/20 0.35
L3MBTL1 Q9Y468 2/20 0.34
POLB P06746 1/20 0.34
MDM4 O15151 1/20 0.34
MITF O75030 1/20 0.34
MDM2 Q00987 1/20 0.34
ATM Q13315 1/20 0.34
GPR35 Q9HC97 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4903708 0.90 LMNA (0.39) LMNAALDH1A1KDM4EHTTSMN1; SMN2
SCHEMBL4899957 0.90 ALDH1A1 (0.40) LMNAALDH1A1KDM4EHTTSMN1; SMN2
SCHEMBL4904091 0.82 ALDH1A1 (0.40) LMNAALDH1A1KDM4EHTTSMN1; SMN2
SCHEMBL4899491 0.79 KMT2A (0.53) LMNAALDH1A1HTTSMN1; SMN2HPGD
SCHEMBL4899866 0.78 LMNA (0.40) LMNAALDH1A1KDM4ESMN1; SMN2HPGD
SCHEMBL4906539 0.78 ALDH1A1 (0.42) LMNAALDH1A1KDM4ERAB9APTGDR2
SCHEMBL4907291 0.76 LMNA (0.50) LMNAALDH1A1KDM4EHTTSMN1; SMN2
SCHEMBL4900643 0.73 KDM4E (0.44) LMNAALDH1A1KDM4EHTTSMN1; SMN2
SCHEMBL4906844 0.73 POLB (0.41) LMNAPTGDR2POLB
SCHEMBL4908224 0.72 HCRTR2 (0.39) LMNAALDH1A1KDM4EHPGDALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD LMNA 319/4885ALDH1A1 2956/4885KDM4E 3834/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD LMNA 319/4885ALDH1A1 2956/4885KDM4E 3834/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.